Redcare Pharmacy Stock - analyst consensus and growth outlook mid-year

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 19:37 CET. Details in the imprint.

Redcare Pharmacy (NL0012044747) is attracting attention from retail investors as they look at the latest analyst estimates and how these line up with the company’s growth ambitions in European online pharmacy. Analysts’ consensus figures give a structured snapshot of expectations around revenue, margins, and profitability for the next few years.

What analysts currently expect

Analyst coverage for Redcare Pharmacy remains comparatively tight, but the available consensus data point to continued top-line growth as the company expands its online pharmacy footprint in Germany and selected European markets. The focus is on scaling volumes while maintaining disciplined cost structures.

Across the published estimates, analysts generally expect revenue to grow at a double-digit percentage pace over the next one to two years, reflecting both underlying prescription demand and over-the-counter categories. Profitability expectations remain more cautious, with attention on logistics efficiency and marketing spending.

Rating stance and consensus ranges

From the available broker views, the rating distribution on Redcare Pharmacy leans toward neutral to constructive, reflecting the balance between strong structural growth drivers and execution risks in a regulated healthcare environment. Price targets where available typically factor in the company’s ambition to further increase market share in core geographies.

Consensus ranges on EBITDA margins show a gradual improvement path as the business gains scale and repeats orders from existing customers. Analysts track the impact of automation in distribution centers, as well as the shift toward higher-margin categories such as private-label health and wellness products.

How the company makes money

Redcare Pharmacy operates a digital-first pharmacy model, selling prescription medicines, over-the-counter drugs, and health-related consumer products through its online platforms to customers in Germany and other European markets. The company earns its revenue primarily from product sales and related pharmacy services.

Where the stock trades today

The shares of Redcare Pharmacy (NL0012044747) trade on Euronext Amsterdam; the latest available price information and market data can be accessed via the company’s home exchange quote pages.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.